Insider Trading Activity For ResMed Inc. (NYSE:RMD)
James Hollingshead , Insider of ResMed Inc. (NYSE:RMD) reportedly Sold 600 shares of the company’s stock at an average price of 84.96 for a total transaction amount of $50,976.00 SEC Form
Insider Trading History For ResMed Inc. (NYSE:RMD)
Analyst Ratings History For ResMed Inc. (NYSE:RMD)
- On 4/27/2016 Piper Jaffray Companies Downgraded rating Overweight to Neutral with a price target of $65.00 to $57.00
- On 4/27/2016 Macquarie Upgraded rating Underperform to Neutral
- On 2/6/2017 Canaccord Genuity Reiterated Rating Hold with a price target of $59.00
- On 4/13/2017 William Blair Reiterated Rating Outperform
- On 8/2/2017 Bank of America Downgraded rating Buy to Neutral
- On 8/2/2017 Citigroup Upgraded rating Neutral to Buy
- On 8/8/2017 Credit Suisse Group Downgraded rating Outperform to Neutral
Dividend Information For ResMed Inc. (NYSE:RMD)
ResMed Inc. (NYSE:RMD) pays an annual dividend of $1.40 with a yield of 1.62% and an average dividend growth of 14.50% (3 Year Average).
Dividend History For ResMed Inc. (NYSE:RMD)
Recent Trading Activity for ResMed Inc. (NYSE:RMD)
Shares of ResMed Inc. closed the previous trading session at 86.50 up +0.08 0.09% with 86.2301025390625 shares trading hands.